Stay updated on Pembrolizumab Effects in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Effects in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Effects in Solid Tumors Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The clinical-trial record is available with details about the pembrolizumab study, including who may participate, how the study is conducted, what it measures, and where it takes place.
    Difference
    49%
    Check dated 2026-11-07T12:51:54.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The site revision identifier changed from v3.7.2 to v3.8.0, while the study page remains unavailable with a 403 Forbidden message.
    Difference
    0.2%
    Check dated 2026-10-31T13:45:55.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The page no longer displays a 403 Forbidden error and instead shows the ClinicalTrials.gov site shell with an NIH notice about its terminology transition from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    2%
    Check dated 2026-10-24T16:09:10.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.1 to v3.7.2. The study record remains inaccessible behind a 403 error.
    Difference
    0.3%
    Check dated 2026-10-17T16:07:15.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.0 to v3.7.1. The study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T15:59:22.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a minimal header and navigation, and a large set of study-related terms appears to have been removed, indicating an access issue rather than an update to core study details.
    Difference
    19%
    Check dated 2026-09-19T18:37:03.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Effects in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Effects in Solid Tumors Clinical Trial page.